Sawicki Mark W
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Sawicki Mark W. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CYRX | Chief Scientific Officer | Sale | 1,349 | $6.94 | $9,362 | Mar 24, 2025 |
| CYRX | Chief Scientific Officer | Award / Grant | 9,000 | — | — | Mar 17, 2025 |
| CYRX | Chief Scientific Officer | Option Exercise | 2,667 | — | — | Mar 10, 2025 |
| CYRX | Chief Scientific Officer | Sale | 1,367 | $17.54 | $23,977 | Mar 25, 2024 |
| CYRX | Chief Scientific Officer | Option Exercise | 2,666 | — | — | Mar 15, 2024 |
| CYRX | Chief Scientific Officer | Option Exercise | 1,000 | $12.79 | $12,790 | Sep 12, 2023 |
| CYRX | Chief Scientific Officer | Award / Grant | 10,455 | — | — | Mar 22, 2023 |
| CYRX | Chief Scientific Officer | Sale | 1,362 | $20.79 | $28,316 | Mar 15, 2023 |
| CYRX | Chief Scientific Officer | Option Exercise | 2,667 | — | — | Mar 13, 2023 |
| CYRX | Chief Scientific Officer | Award / Grant | 10,455 | — | — | Mar 14, 2022 |
| CYRX | Chief Scientific Officer | Sale | 1,410 | $31.05 | $43,781 | Mar 9, 2022 |
| CYRX | Chief Scientific Officer | Sale | 3,172 | $59.11 | $187,497 | Aug 11, 2021 |
| CYRX | Chief Scientific Officer | Option Exercise | 7,231 | $1.87 | $13,522 | Mar 10, 2021 |